Meeting report (part 2): Biological treatment of rheumatic diseases with special focus on T cell modulation

Meeting report (part 2): Biological treatment of rheumatic diseases with special focus on T cell modulation

The meeting at Karolinska Institute Center for Molecular Medicine continued with a very interesting state-of-the-art lecture on safety of biologic treatment in rheumatic diseases, given by Johan Askling, associate professor rheumatology (photo). His lecture was structured in three sections: first some facts about cancer occurrence in rheumatoid arthritis, then a part adressing cancer occurrence related to treatment strategeis of rheumatoid artritis, and finally some clinical considerations to conclude with.